Home Cart Sign in  
Chemical Structure| 133-89-1 Chemical Structure| 133-89-1

Structure of Uridine diphosphate glucose
CAS No.: 133-89-1

Chemical Structure| 133-89-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Uridine diphosphate glucose is a nucleotide sugar. It is involved in glycosyltransferase reactions in metabolism.

Synonyms: Uridine diphosphate glucose

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Uridine diphosphate glucose

CAS No. :133-89-1
Formula : C15H24N2O17P2
M.W : 566.30
SMILES Code : O[C@@H]1[C@H](O[C@H](OP(O)(OP(O)(OC[C@H]2O[C@@H](N3C=CC(NC3=O)=O)[C@H](O)[C@@H]2O)=O)=O)[C@H](O)[C@H]1O)CO
Synonyms :
Uridine diphosphate glucose
MDL No. :MFCD14155949
InChI Key :HSCJRCZFDFQWRP-JZMIEXBBSA-N
Pubchem ID :8629

Safety of Uridine diphosphate glucose

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RBL-2H3 mast cells 10 µM 1-60 minutes To investigate UDPG-induced MAPK activation. Results showed UDPG induced phosphorylation of ERK1/2, P38 and JNK, with the strongest activation of P38 (>3-fold of basal value). Biochem Pharmacol. 2010 Mar 15;79(6):873-9
RBL-2H3 mast cells 1150 ± 320 nM (UDPG), 103 ± 18 nM (MRS2690) 20 minutes To investigate the role of UDPG in mediating mast cell degranulation via P2Y14 receptor. Results showed UDPG and its analog MRS2690 concentration-dependently enhanced antigen-induced HEX release, and this effect was completely blocked by pertussis toxin. Biochem Pharmacol. 2010 Mar 15;79(6):873-9
Rat cortical neurons 100 µM 24 hours To evaluate the effect of UDP-G on neuronal apoptosis, results showed that UDP-G decreased cell viability and increased apoptotic marker CC3 levels and TUNEL positive neurons Stroke. 2024 May;55(5):1381-1392
INS-1 832/13 cells 10 mM 24 hours To investigate the effect of UDP-G on cell proliferation, results showed UDP-G suppressed cell proliferation under high glucose conditions. J Biol Chem. 2020 Nov 6;295(45):15245-15252
INS-1 832/13 cells 10 mM 60 minutes To investigate the inhibitory effect of UDP-G on GSIS and cAMP generation, results showed UDP-G suppressed GSIS and reduced cAMP levels. J Biol Chem. 2020 Nov 6;295(45):15245-15252
Human pancreatic islets 10 mM 60 minutes To investigate the inhibitory effect of UDP-G on glucose-stimulated insulin secretion (GSIS), results showed UDP-G dose-dependently suppressed GSIS. J Biol Chem. 2020 Nov 6;295(45):15245-15252
INS-1 832/13 cells 10 mM 72 hours To investigate the effect of UDP-G on apoptosis, results showed UDP-G increased apoptosis under high glucose conditions. J Biol Chem. 2020 Nov 6;295(45):15245-15252

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Subarachnoid hemorrhage model Intranasal administration 50μg/kg PPTN or 7.1mg/kg UDP-G Single dose at 1 hour after SAH To evaluate the effects of P2Y14 inhibitor PPTN and activator UDP-G on neurological function after SAH, results showed that PPTN improved neurological function and reduced neuronal apoptosis, while UDP-G exacerbated these outcomes Stroke. 2024 May;55(5):1381-1392

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.77mL

0.35mL

0.18mL

8.83mL

1.77mL

0.88mL

17.66mL

3.53mL

1.77mL

 

Historical Records